Immunity-Guided Identification of Threonyl-tRNA Synthetase as the Molecular Target of Obafluorin, a β‑Lactone Antibiotic

• Published in: ACS chemical biology Vol. 14; no. 12; pp. 2663 - 2671
• Main Authors: Scott, Thomas A, Batey, Sibyl F. D, Wiencek, Patrick, Chandra, Govind, Alt, Silke, Francklyn, Christopher S, Wilkinson, Barrie
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 20-12-2019
• Subjects: Anti-Bacterial Agents - metabolism; Gram-Negative Bacteria - drug effects; Gram-Positive Bacteria - drug effects; Lactones - metabolism; Lactones - pharmacology; Microbial Sensitivity Tests; Threonine-tRNA Ligase - metabolism
• ISSN: 1554-8929; 1554-8937
• DOI: 10.1021/acschembio.9b00590

To meet the ever-growing demands of antibiotic discovery, new chemical matter and antibiotic targets are urgently needed. Many potent natural product antibiotics which were previously discarded can also provide lead molecules and drug targets. One such example is the structurally unique β-lactone obafluorin, produced by Pseudomonas fluorescens ATCC 39502. Obafluorin is active against both Gram-positive and -negative pathogens; however, the biological target was unknown. We now report that obafluorin targets threonyl-tRNA synthetase, and we identify a homologue, ObaO, which confers immunity to the obafluorin producer. Disruption of obaO in P. fluorescens ATCC 39502 results in obafluorin sensitivity, whereas expression in sensitive E. coli strains confers resistance. Enzyme assays demonstrate that E. coli threonyl-tRNA synthetase is fully inhibited by obafluorin, whereas ObaO is only partly susceptible, exhibiting a very unusual partial inhibition mechanism. Altogether, our data highlight the utility of an immunity-guided approach for the identification of an antibiotic target de novo and will ultimately enable the generation of improved obafluorin variants.